Identify, ablate and biopsy tumors on the same platform.
Tissue Conductivity Profiling (TCP) uses impedance spectroscopy to distinguish tumor from normal tissue.
Programmable Impedance Field Shaping (PIFS) steers current to ablate, then senses impedance to measure the extent of the ablation, check for residual tumor and retarget.
TCP distinguishes cystic, calcified, vascular and neural components, with nerve localization when the biopsy path runs near neural pathways.
